TAXUS ARRIVE 2: A Multi-Center Safety Surveillance Program

Completed · Phase 4

Conditions studied: Cardiovascular Disease, de Novo Coronary Lesions

In brief

The TAXUS ARRIVE 2 study is a multi-center safety and surveillance study designed to to compile safety surveillance and clinical outcomes data for the TAXUS™ Express2™ Paclitaxel-Eluting Coronary Stent System in routine clinical practice and to identify low frequency TAXUS related clinical events.

Key facts

Study ID
NCT00569751
Run by
Boston Scientific Corporation
People needed
5016
Starts
2004-10-01
Expected to finish
2008-07-01
Last updated by the study team
2008-09-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.